Sterling Biotech reports net loss of Rs 103.33 crore in the March 2014 quarter

Sales decline 8.53% to Rs 188.21 crore

Net Loss of Sterling Biotech reported to Rs 103.33 crore in the quarter ended March 2014 as against net loss of Rs 96.10 crore during the previous quarter ended March 2013. Sales declined 8.53% to Rs 188.21 crore in the quarter ended March 2014 as against Rs 205.76 crore during the previous quarter ended March 2013. ParticularsQuarter EndedMar. 2014Mar. 2013% Var.Sales188.21205.76 -9 OPM %19.5212.92 -PBDT-89.07-78.92 -13 PBT-152.96-142.26 -8 NP-103.33-96.10 -8

Powered by Capital Market - Live News